Pediatrics

Two doses of BNT162b2 moderately effective for 5- to 11-year-olds

For children aged 5 to 11 years, two doses of BNT162b2 provide moderate protection against documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and symptomatic COVID-19, according to a study published ...

Diseases, Conditions, Syndromes

ACC: Pericardial effusion prevalent in hospitalized COVID-19 patients

Pericardial effusion is prevalent among hospitalized patients with COVID-19, but is rarely due to pericarditis, according to a study published online March 21 in the Journal of the American Heart Association, ahead of presentation ...

Parkinson's & Movement disorders

COVID-19 vaccines do not impact IVF success

(HealthDay)—Receipt of a COVID-19 mRNA vaccine does not affect the ovarian response or pregnancy rates in in vitro fertilization (IVF) treatment, according to a study published online Feb. 25 in Fertility and Sterility.

Vaccination

Israeli expert panel advises 4th vaccine dose for adults

An expert panel on Tuesday advised the Israeli government to begin offering a fourth vaccine dose to everyone over the age of 18, citing research showing it helps prevent COVID-19 infection and severe illness.

page 2 from 11